loading page

Investigation of the ubiquitin proteasome system in pulmonary arterial hypertension
  • +5
  • Yu Li,
  • Mianli Bian,
  • Shujun Gu,
  • Xinyu Wang,
  • Jingli Wen,
  • Naqi Lian,
  • Miao Jiang,
  • Xu Qi
Yu Li

Corresponding Author:[email protected]

Author Profile
Mianli Bian
Author Profile
Xinyu Wang
Author Profile
Jingli Wen
Author Profile
Miao Jiang
Author Profile


Ubiquitin proteasome system (UPS) is the major avenues approach of protein degradation, which is responsible for 80% protein degradation in eukaryotic cells. Recently, UPS is involved in a variety of disease processes and plays a significant role in DNA repair, transcription regulation, autophagy and protein transport. Pulmonary arterial hypertension (PAH) is a disease mainly caused by pulmonary artery endothelial cell (PAEC) dysfunction and pulmonary artery smooth muscle cell (PASMC) excessive proliferation and abnormal apoptosis. These increased pulmonary vascular resistance, vascular remodeling, and finally leading to the failure of right heart. The alteration of pulmonary artery protein ubiquitination occurs at the initial stage of PAH and participates in several cell pathways, such as vasoconstriction, tissue remodeling/angiogenesis, cell migration and calcium signaling. In this review, we mainly introduce the functional changes of UPS in PAH, especially specific E3 ubiquitin ligases with related endoplasmic reticulum stress (ERS), proteolysis-targeting chimeras (PROTACs) and proteasome inhibitors mediated degradation mechanism, providing new ideas for the precise diagnosis and treatment of PAH.